HUM vs OBIO · P/E 39, rev $117.76B vs rev $2.6M
Humana Inc (HUM) versus Orchestra BioMed Holdings Inc. (OBIO) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported OBIO revenue for 2024-12-31 was $2.6M. Net income was -$61.0M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. OBIO currently screens at market cap $231.7M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. OBIO currently screens at market cap $231.7M.
Not investment advice. Open the HUM and OBIO stock pages for the full models.
Not investment advice.